Brief Report: Mapping Colorectal Distribution of Cell-Free and Cell-Associated HIV Surrogates Following Simulated Anal Intercourse to Aid Rectal Microbicide Development

Ethel D. Weld, Ken Ogasawara, Edward J. Fuchs, Nicolette Louissaint, Brian Caffo, Craig W. Hendrix

Research output: Contribution to journalArticlepeer-review

Abstract

Background:Anal sex remains the greatest HIV transmission risk for men who have sex with men and carries substantial population attributable risk among women. Despite a growing array of HIV preexposure prophylaxis (PrEP) options, rectal microbicides remain desirable as on-demand, nonsystemic PrEP. Rectal microbicide product development for PrEP requires understanding the spatiotemporal distribution of HIV infectious elements in the rectosigmoid to optimize formulation development.Setting:Outpatient setting with healthy research participants.Methods:Six healthy men underwent simulated receptive anal sex with an artificial phallus fitted with a triple-lumen catheter in the urethral position. To simulate ejaculation of HIV-infected semen, autologous seminal plasma laden with autologous blood lymphocytes from apheresis labeled with 111Indium-oxine (cell-associated) and 99mTechnetium-sulfur colloid (cell-free) as HIV surrogates was injected into the rectal lumen through the phallic urethra. Spatiotemporal distribution of each radioisotope was assessed using single-photon emission computed tomography/CT over 8 hours. Analysis of radiolabel distribution used a flexible principal curve algorithm to quantitatively estimate rectal lumen distribution.Results:Cell-free and cell-associated HIV surrogates distributed to a maximal distance of 15 and 16 cm, respectively, from the anorectal junction (∼19 and ∼20 cm from the anal verge), with a maximal signal intensity located at 6 and 7 cm, respectively. There were no significant differences in any distribution parameters between cell-free and cell-associated HIV surrogates.Conclusions:Cell-free and cell-associated HIV surrogate distribution in the rectosigmoid can be quantified with spatiotemporal pharmacokinetic methods. These results describe the ideal luminal target distribution to guide rectal microbicide development.

Original languageEnglish (US)
Pages (from-to)18-22
Number of pages5
JournalJournal of Acquired Immune Deficiency Syndromes
Volume96
Issue number1
DOIs
StatePublished - May 1 2024

Keywords

  • HIV
  • SPECT/CT imaging
  • anal sex
  • pharmacokinetics
  • preexposure prophylaxis
  • rectal microbicide

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Brief Report: Mapping Colorectal Distribution of Cell-Free and Cell-Associated HIV Surrogates Following Simulated Anal Intercourse to Aid Rectal Microbicide Development'. Together they form a unique fingerprint.

Cite this